IHC Marker – Vimentin Test: Booking, Price, and Results
About IHC Marker – Vimentin Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | Vimentin IHC, Vimentin Immunostain, VIM IHC, Vimentin Immunohistochemistry |
| Sample Type | Tissue biopsy (FFPE block — formalin-fixed, paraffin-embedded tissue) |
| Fasting Required | No. This test is performed on preserved tissue, not blood or urine |
| Report Time | 7 days |
| Recommended For | All genders and age groups; ordered when investigating suspected tumours |
| Price | Starting at ₹1,920 |
What Is an IHC Marker – Vimentin Test?
The IHC Marker – Vimentin test is a specialised laboratory test that detects the vimentin protein in biopsy tissue using a technique called 'immunohistochemistry' (IHC). Doctors order this test to determine the origin and type of a tumour. Also known as 'Vimentin Immunostain' or 'VIM IHC', it is performed on a tissue sample that has already been collected through a biopsy.
What Does an IHC Marker – Vimentin Test Measure?
The IHC Marker – Vimentin test procedure detects the presence and distribution of vimentin, a structural protein found naturally in mesenchymal cells (cells of connective tissue origin). The result helps pathologists determine whether the cells under examination are of mesenchymal origin. The following table explains what the test looks for and why it matters.
| Component | What It Tells the Pathologist |
|---|---|
| Vimentin protein expression | Indicates whether the tumour cells are of mesenchymal origin |
| Staining intensity | Helps assess how strongly vimentin is expressed in tumour cells |
| Extent of staining | Shows what proportion of cells in the tissue sample test positive |
| Pattern of distribution | Assists in distinguishing between tumour types within a diagnostic panel |
The test does not produce numerical values. Results are reported based on the presence, intensity and pattern of staining seen under the microscope.
Why Is an IHC Marker – Vimentin Test Done?
The Vimentin IHC test is used when a standard biopsy cannot provide a clear diagnosis on its own. It is typically part of a broader panel of markers examined together to classify tumours accurately.
Common Symptoms That May Require This Test
A doctor may recommend this test when a biopsy has already been taken and tissue analysis is needed. The following situations commonly lead to this test being ordered:
- An unexplained lump or mass anywhere in the body
- Abnormal biopsy findings that need further classification
- Suspected soft tissue tumour
- Suspected cancer of unknown origin that has spread (metastasised)
- Kidney tumour findings on imaging
- Skin lesions suspicious for melanoma
Conditions This Test Can Help Detect
The Vimentin Immunostain test assists in identifying a range of conditions. These include:
- Sarcomas such as fibrosarcoma, angiosarcoma, leiomyosarcoma and rhabdomyosarcoma (cancers arising from connective tissue)
- Lymphomas (blood cancers originating from lymphocytes, a type of white blood cell)
- Melanomas (skin cancers) and schwannomas (nerve sheath tumours), which are strongly vimentin-positive
- Clear cell renal cell carcinoma (a type of kidney cancer that shows vimentin expression in virtually all cases)
- Endometrial carcinoma (uterine cancer)
- Certain carcinomas that co-express vimentin alongside other markers, such as some thyroid carcinomas and pleomorphic adenomas of the salivary glands
Vimentin is typically negative in most epithelial carcinomas (cancers arising from lining tissues), which makes it useful for distinguishing between tumour types.
How to Prepare and What to Expect
Preparation for the IHC Marker – Vimentin test is straightforward, as the test is performed on tissue already obtained through a biopsy.
Do You Need to Fast?
No fasting is required. This test analyses preserved tissue samples, not blood or urine, so food intake does not affect the results. Preparation relates entirely to gathering the correct tissue sample and documentation.
Practical Tips Before Your Test
Being organised before your appointment helps ensure the test runs smoothly. Keep the following in mind:
- Bring a detailed clinical history, including your symptoms, previous test results and family history, as this is required for the test.
- Carry your doctor's referral letter, including the biopsy site details.
- Bring any existing histopathology reports if you are submitting a paraffin block.
- Include relevant imaging reports such as CT scans, MRIs, PET scans or X-rays.
- Inform the laboratory about any medications you are currently taking.
Step-by-Step Procedure
The IHC Marker – Vimentin test procedure involves laboratory processing of a biopsy tissue sample. Here is what happens from sample collection to result:
- A doctor collects a tissue sample from the affected area through a biopsy. The method depends on the location and type of lesion — this may be a needle biopsy or a surgical excision. No separate sample collection is needed for the IHC test itself.
- The tissue sample is placed in a formalin solution to preserve it, then embedded in a paraffin wax block, forming what is called an FFPE block.
- A laboratory technician cuts very thin slices from the tissue block using a precision instrument called a microtome.
- The thin tissue slices are placed on glass slides and treated with antibodies that bind specifically to vimentin protein in the cells.
- A detectable marker attached to these antibodies (such as an enzyme or dye) makes the vimentin protein visible under a microscope.
- A qualified pathologist examines the stained slides and reports whether vimentin staining is present, noting the intensity and distribution of the staining pattern.
Factors That Can Affect Accuracy
The following factors can influence the reliability of your results:
- Over-fixation in formalin can reduce the detectability of vimentin protein
- Tissue damaged by necrosis (cell death) or poorly preserved samples may show inconsistent staining
- The quality and adequacy of the biopsy sample collected
- The age of the cut paraffin section, as older sections may show reduced immunoreactivity
- Antibody quality, laboratory processing standards and the pathologist's expertise
Understanding Your IHC Marker – Vimentin Test Results
Results of the Vimentin IHC test should always be reviewed alongside your clinical history, imaging findings and other laboratory results. Your treating doctor or pathologist is best placed to interpret what the findings mean for your specific situation.
| Parameter | Expected Finding | Interpretation |
|---|---|---|
| Vimentin staining | Positive | Vimentin protein detected, suggests mesenchymal origin or epithelial-to-mesenchymal transition in tumour cells |
| Vimentin staining | Negative | Vimentin protein not detected; typically seen in standard epithelial tumours without mesenchymal features |
Positive staining may be associated with sarcomas, lymphomas, melanomas, schwannomas and clear cell renal cell carcinoma. Negative staining can assist in identifying chromophobe renal cell carcinoma, renal oncocytoma and endocervical adenocarcinoma, among others.
Disclaimer: These ranges are general guidelines. Your doctor will interpret your results based on your age, health history and other factors. Always consult a qualified healthcare professional for personalised medical advice.
How to Maintain Healthy Levels
The Vimentin Immunostain test is a diagnostic test for tumour classification, not a wellness screening tool. General lifestyle choices do not influence vimentin expression. The following steps are appropriate after receiving results:
- Attend regular health check-ups and report any new or unusual lumps promptly.
- Share all relevant medical history and imaging reports with your doctor to support accurate interpretation.
- Follow your doctor's guidance for any further testing or evaluation based on your results.
Lupin Diagnostics IHC Marker-Vimentin Test Price
The IHC marker – Vimentin test cost at Lupin Diagnostics starts at ₹1,920. This test requires a visit to a Lupin Diagnostics centre; home collection is not available, as tissue samples from biopsies must be handled and processed under controlled laboratory conditions.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 1920 |
| CHENNAI | 1920 |
| HYDERABAD | 1920 |
| KOLKATA | 1920 |
| NAVI MUMBAI | 1920 |
| PUNE | 1920 |
Disclaimer: Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps for IHC Marker – Vimentin test online booking:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time for sample submission.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
The IHC Marker – Vimentin test helps pathologists identify the origin and type of suspected tumours. Vimentin is a protein found in mesenchymal cells, and its presence or absence in tissue helps distinguish between different types of cancers, such as sarcomas, melanomas and carcinomas.
No. This test requires a tissue sample obtained through a biopsy, which must be performed at a healthcare centre. The processed tissue block is then submitted to the laboratory directly.
The report is typically available within 7 days. Turnaround time may vary depending on the complexity of the panel and the condition of the tissue sample submitted.
A positive result means vimentin protein was detected in the tissue sample. This generally indicates that the cells are of mesenchymal origin, which may be consistent with tumour types such as sarcomas, melanomas or lymphomas. Your pathologist will interpret this finding alongside other markers and clinical information.
Not necessarily. Vimentin is naturally present in normal mesenchymal cells, including fibroblasts, endothelial cells and macrophages. A positive result simply indicates the tissue contains cells of mesenchymal origin. Your doctor interprets this finding alongside other markers, imaging and clinical information.
A negative result can help rule out tumours of mesenchymal origin. It may support a diagnosis of chromophobe renal cell carcinoma, renal oncocytoma or endocervical adenocarcinoma, among others. Your pathologist combines this result with other IHC markers and clinical findings to reach a final diagnosis.
No. Vimentin is typically used as part of a broader panel of IHC markers. It provides one piece of information that, when combined with other test findings, clinical history and imaging results, helps arrive at a diagnosis. A single marker is rarely sufficient for a definitive conclusion.
Tissue quality is one of the most important factors. Prolonged formalin fixation, poor sample preservation or tissue damaged by necrosis can all affect how well the antibodies bind to the protein. Laboratory processing standards and the pathologist's expertise also play a role in result accuracy.
IHC Marker – Vimentin Test: Booking, Price, and Results
